|
SARS CoV-2 spike protein in DIBMA Glycerol |
21-816 |
0.1 mg |
PROSCI |
|
|
|
|
SARS CoV-2 spike protein in LMNG detergent |
21-815 |
0.1 mg |
PROSCI |
|
|
|
|
SARS CoV-2 spike protein nanodisc complex |
21-817 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) 501Y.V2/V3 variant S RBD (E484K) Recombinant Protein |
11-067 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody |
9359 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody |
9359 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [1G8D11] |
PM-9373 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [1G8D11] |
PM-9373 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [7A4D12] |
PM-9374 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [7A4D12] |
PM-9374 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [7C11H11] |
PM-9375 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [7C11H11] |
PM-9375 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [9F7E4] |
PM-9371 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Antibody [9F7E4] |
PM-9371 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike RBD Recombinant Protein |
21-824 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein |
21-808 |
50ug |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein |
21-811 |
50ug |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein |
21-825 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike S1 (RBD) Recombinant Protein |
21-809 |
50ug |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike S1 (RBD) Recombinant Protein |
21-812 |
50ug |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Brazil variant (501Y.V3) S RBD (K417T, E484K, N501Y) Recombinant Protein |
11-066 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Delta Variant Spike RBD (His-Avi Tag) Recombinant Protein |
95-126 |
0.05mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Delta Variant Spike S1 (His-Avi Tag) Recombinant Protein |
95-127 |
0.05mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Full-Length Alpha Variant (B.1.1.7, UK) Spike Recombinant Protein |
21-818 |
0.025mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Full-Length Beta Variant (B.1.351, SA) Spike Recombinant Protein |
21-819 |
0.025mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Full-Length Epsilon Variant (B.1.429, Ca) Spike Recombinant Protein |
21-822 |
0.025mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Full-Length Eta Variant (B.1.525, UK) Spike Recombinant Protein |
21-821 |
0.025mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Full-Length Gamma Variant (P.1, Brazil) Spike Recombinant Protein |
21-820 |
0.025mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein |
21-823 |
0.025mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) full-length Spike S1 Alpha (United Kingdom, Sept 2020) B.1.1.7 Variant RP |
21-818 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) full-length Spike S1 Beta (South Africa, May 2020) B.1.351 Variant RP |
21-819 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) full-length Spike S1 Epsilon (California) B.1.429 Variant RP |
21-822 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) full-length Spike S1 Eta (United Kingdom, Dec 2020) B.1.525 Variant RP |
21-821 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) full-length Spike S1 Gamma (Brazil, Nov 2020) P.1 Variant RP |
21-820 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) full-length Spike S1 Kappa (India, Dec 2020) B.1.617.1 Variant RP |
21-823 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Gamma Variant (P.1, Brazil) Spike RBD Recombinant Protein |
21-826 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Gamma Variant (P.1, Brazil) Spike S1 (RBD) Variant Recombinant Protein |
21-813 |
50ug |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Gamma Variant (P.1, Brazil) Spike S1 (RBD) Variant Recombinant Protein |
21-810 |
50ug |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Kappa Variant (B.1.617, India) Spike RBD (E484Q, L452R) Recombinant Protein |
20-185 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) S Protein HR1 Recombinant Protein |
92-760 |
0.05 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) S-trimer 6P Recombinant Protein |
11-068 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) S-trimer Protein Recombinant Protein |
92-748 |
0.05 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) S1 Protein Recombinant Protein |
92-746 |
0.05 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) South African variant (501Y.V2) S RBD (K417N, E484K, N501Y) Recombinant Protein |
11-065 |
0.1 mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody |
9685 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody |
9685 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Spike 156-157EFdel Antibody (Delta Variant) |
9689 |
0.1mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Spike 156-157EFdel Antibody (Delta Variant) |
9689 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Spike 26P Antibody |
PM-9583 |
0.02mg |
PROSCI |
|
|
|
|
SARS-CoV-2 (COVID-19) Spike 26P Antibody |
PM-9583 |
0.1mg |
PROSCI |
|
|
|